Pharmacological activation of GLT-1 alleviated VGluT2 neuron hyperexcitability, as well as abdominal visceral pain and anxiety-like behaviors, suggesting GLT-1 as a potential therapeutic target for CP-related pain (Luo et al., 2024). The gene discussed is SLC1A2; the disease is Anxiety.